Highlights:
125I RSI-BT was a safe and feasible salvage treatment
for recurrent NPC after EBRT.
Frequency of previous EBRT was a prognostic factor influencing LC and
OS.
Patients with recurrent NPC after EBRT, especially those treated with
re-irradiation might benefit from 125I RSI-BT.